Daniil Talyanskiy
Director/Board Member at Generium ZAO
Profile
Daniil Talyanskiy is currently the Director & Deputy Chief Executive Officer at Generium ZAO since 2017.
He is also the Chief Business Officer & Deputy CEO at International Biotech Center Generium, LLC since 2011.
Additionally, he holds the position of Director at OncoTartis LLC.
Formerly, Mr. Talyanskiy served as an Independent Director at Cleveland BioLabs, Inc. from 2016 to 2021.
He was also a Director at Affitech A.
Prior to that, he was a Member-Supervisory Board at co.don AG from 2015 to 2016.
He started his career as the Head-Corporate University at Oboronprom United Industrial Corp.
JSC from 2008 to 2011.
Mr. Talyanskiy obtained his graduate degree from Togliatti Academy of Management in 2007.
Daniil Talyanskiy active positions
| Companies | Position | Start |
|---|---|---|
Generium ZAO
 Generium ZAO Pharmaceuticals: MajorHealth Technology Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development. | Director/Board Member | 2016-12-31 |
International Biotech Center Generium, LLC
 International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | Corporate Officer/Principal | 2010-12-31 |
OncoTartis LLC
 OncoTartis LLC BiotechnologyHealth Technology Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | Director/Board Member | - |
Former positions of Daniil Talyanskiy
| Companies | Position | End |
|---|---|---|
| STATERA BIOPHARMA, INC. | Director/Board Member | 2021-07-26 |
| CO.DON AG | Director/Board Member | 2016-08-14 |
Oboronprom United Industrial Corp. JSC
 Oboronprom United Industrial Corp. JSC Aerospace & DefenseElectronic Technology Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation. | Corporate Officer/Principal | 2010-12-31 |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Training of Daniil Talyanskiy
| Togliatti Academy of Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CO.DON AG | Health Services |
| Private companies | 6 |
|---|---|
Generium ZAO
Generium ZAO Pharmaceuticals: MajorHealth Technology Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development. | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
International Biotech Center Generium, LLC
International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | Commercial Services |
Oboronprom United Industrial Corp. JSC
Oboronprom United Industrial Corp. JSC Aerospace & DefenseElectronic Technology Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation. | Electronic Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
OncoTartis LLC
OncoTartis LLC BiotechnologyHealth Technology Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Daniil Talyanskiy
